{{Rsnum
|rsid=1017745
|Chromosome=18
|position=75815681
|Orientation=plus
|GMAF=0.3939
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.3 | 57.1 | 28.6
| HCB | 6.6 | 31.4 | 62.0
| JPT | 3.5 | 29.2 | 67.3
| YRI | 32.7 | 49.0 | 18.4
| ASW | 28.1 | 50.9 | 21.1
| CHB | 6.6 | 31.4 | 62.0
| CHD | 4.6 | 27.5 | 67.9
| GIH | 8.9 | 45.5 | 45.5
| LWK | 36.4 | 46.4 | 17.3
| MEX | 8.6 | 46.6 | 44.8
| MKK | 32.7 | 42.3 | 25.0
| TSI | 19.6 | 48.0 | 32.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=6E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}